Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Alzheimer's disease research and treatments

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,907 works 100 author topics

Works

1,907 works

  1. Neuroprotective Effects of Quercetin in Alzheimer Disease 2020
    YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.7%

    Quercetin is a flavonoid with notable pharmacological effects and promising therapeutic potential. It is widely distributed among plants and found commonly in daily diets predominantly in fruits and vegetables. Neuroprotection by quercetin has been reported in several in vitro studies. It has been shown to protect neu…

  2. The antioxidants α‐lipoic acid and N ‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice 2003
    OpenAlex top 1% OpenAlex 99.7%

    Oxidative stress may play a crucial role in age-related neurodegenerative disorders. Here, we examined the ability of two antioxidants, alpha-lipoic acid (LA) and N-acetylcysteine (NAC), to reverse the cognitive deficits found in the SAMP8 mouse. By 12 months of age, this strain develops elevated levels of Abeta and s…

  3. Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin 2011
    OpenAlex top 1% OpenAlex 99.1%

    Alzheimer's disease (AD) is a highly complex neurodegenerative disorder of the aged that has multiple factors which contribute to its etiology in terms of initiation and progression. This review summarizes these diverse aspects of this form of dementia. Several hypotheses, often with overlapping features, have been fo…

  4. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer s Disease 2012
    YÖKSİS OpenAlex top 1% OpenAlex 99.3%

    BACKGROUND: The identification of early mechanisms underlying Alzheimer's Disease (AD) and associated biomarkers could advance development of new therapies and improve monitoring and predicting of AD progression. Mitochondrial dysfunction has been suggested to underlie AD pathophysiology, however, no comprehensive stu…

  5. Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts 2020
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  6. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer’s disease 2010
    YÖKSİS SJR Q3 JCR Q3 OpenAlex top 1% OpenAlex 99.3%

    No abstract yet.

  7. The interleukin 1 alpha interleukin 1 beta interleukin 6 and alpha 2 macroglobulin serum levels in patients with early or late onset Alzheimer s disease mild cognitive impairment or Parkinson s disease 2015
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  8. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’xxs disease, mild cognitive impairment or Parkinson’xxs disease 2015
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  9. Mechanisms of Alzheimer’s Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors 2017
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 98.2%

    The characteristic features of Alzheimer's disease (AD) are the appearance of extracellular amyloid-beta (Aβ) plaques and neurofibrillary tangles in the intracellular environment, neuronal death and the loss of synapses, all of which contribute to cognitive decline in a progressive manner. A number of hypotheses have…

  10. Decision-making cognition in neurodegenerative diseases 2010
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 99.0%

    No abstract yet.

  11. The interleukin 1 alpha interleukin 1 beta interleukin 6 and alpha 2 macroglobulin serum levels in patients with early or late onset Alzheimer s disease mild cognitive impairment or Parkinson s disease 2015
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.3%

    No abstract yet.

  12. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies 2017
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.7%

    α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases known as synucleinopathies. The toxic properties of α-synuclein are conserved from yeast to man, but the precise underpinnings of the cellular pathologies associated are still elusive, complicati…

Academicians

100 academicians